Scientists are launching human trials of a “life-changing” drug that can alleviate involuntary and erratic “jerking” caused by Parkinson’s medication. Here’s the latest on the groundbreaking research.
The drug, NLX-112, has the potential to reduce dyskinesia and “improve movement symptoms of Parkinson’s”, said Parkinson’s UK.
The research charity explained: “Dyskinesias are involuntary, erratic, writhing movements of the face, arms, legs or trunk.
“They may also cause rapid jerking or slow and extended muscle spasms.”